Overview
Clinical Meaning
Heart Failure Advanced centers on progressive myocardial dysfunction.
AGPCNP
AGPCNP
Heart Failure Advanced centers on progressive myocardial dysfunction. In systolic HF (HFrEF, EF <=40%), cardiomyocyte loss from ischemia, toxins, or genetic causes reduces contractile force. Compensatory neurohormonal activation (RAAS, sympathetic nervous system, natriuretic peptides) initially maintains cardiac output but chronically causes adverse remodeling: ventricular dilation, interstitial fibrosis, and further myocyte apoptosis. Elevated angiotensin II promotes vasoconstriction, aldosterone-mediated sodium/water retention, and myocardial fibrosis. Sustained sympathetic activation causes beta-receptor downregulation and direct myocyte toxicity. B-type natriuretic peptide (BNP) is released from stretched ventricular myocytes.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this AGPCNP pathway. You can still explore topic-filtered questions from the bank hubs below.